The cytokine-stimulated activation of NF-kappaB has been shown to be essential for the expression of genes controlled by the HIV LTR and for the expression of the AIDS virus itself. Our recent studies demonstrate that depleting intracellular glutathione (GSH) markedly facilities NF- kappaB activation. We have shown that N-acetylcysteine (NAC), a non- toxic drug used clinically to replenish GSH and to scavenge intracellular oxidants in paracetamol (Tylenol) poisoning, replenishes GSH and blocks cytokine-stimulated HIV replication in acutely and chronically infected cell lines and in normal peripheral blood mononuclear cells infected in vitro. These findings are explained by the recognition of a thiol-sensitive step in the signal transduction pathway through which cytokines such as TNF-alpha stimulated NF-kappaB activation. Since intracellular GSH levels tend to be low in HIV-infected individuals and TNF-alpha levels tend to be high, our findings suggest that the replenishment of intracellular thiols (e.g., by continued treatment with NAC) could be beneficial clinically. For patients with frank AIDS, NAC therapy could provide an effective means for overcoming the toxicity due to excessive cytokine stimulation (e.g., wasting) and possibly for slowing the progression of the HIV infection. For ARC patients, it could interrupt the cytokine/viral expression cycle that results in physical deterioration and progression to AIDS. Finally, for asymptomatic, HIV-positive individuals, it could help to maintain the virus in a latent state and thus prevent initiation of the progression to AIDS. Studies proposed here concentrate on further exploration of the mechanisms through which intracellular thiols influence signal transduction, transcription factor production/activation and the cytokine-stimulated expression of genes in general and HIV in particular.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI031770-03
Application #
2066700
Study Section
AIDS and Related Research Study Section 3 (ARRC)
Project Start
1992-03-01
Project End
1995-02-28
Budget Start
1994-03-01
Budget End
1995-02-28
Support Year
3
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Stanford University
Department
Genetics
Type
Schools of Medicine
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305
Torres-Roca, J F; Tung, J W; Greenwald, D R et al. (2000) An early oxygen-dependent step is required for dexamethasone-induced apoptosis of immature mouse thymocytes. J Immunol 165:4822-30
Mitra, D K; De Rosa, S C; Luke, A et al. (1999) Differential representations of memory T cell subsets are characteristic of polarized immunity in leprosy and atopic diseases. Int Immunol 11:1801-10
Roederer, M; Raju, P A; Mitra, D K et al. (1997) HIV does not replicate in naive CD4 T cells stimulated with CD3/CD28. J Clin Invest 99:1555-64
Watanabe, N; De Rosa, S C; Cmelak, A et al. (1997) Long-term depletion of naive T cells in patients treated for Hodgkin's disease. Blood 90:3662-72
Roederer, M; De Rosa, S; Gerstein, R et al. (1997) 8 color, 10-parameter flow cytometry to elucidate complex leukocyte heterogeneity. Cytometry 29:328-39
Katsikis, P D; Garcia-Ojeda, M E; Torres-Roca, J F et al. (1997) HIV type 1 Tat protein enhances activation-but not Fas (CD95)-induced peripheral blood T cell apoptosis in healthy individuals. Int Immunol 9:835-41
Katsikis, P D; Garcia-Ojeda, M E; Wunderlich, E S et al. (1996) Activation-induced peripheral blood T cell apoptosis is Fas independent in HIV-infected individuals. Int Immunol 8:1311-7
Nakamura, H; De Rosa, S; Roederer, M et al. (1996) Elevation of plasma thioredoxin levels in HIV-infected individuals. Int Immunol 8:603-11
Roederer, M; Herzenberg, L A; Herzenberg, L A (1996) Changes in antigen densities on leukocyte subsets correlate with progression of HIV disease. Int Immunol 8:1-11
Rabin, R L; Roederer, M; Maldonado, Y et al. (1995) Altered representation of naive and memory CD8 T cell subsets in HIV-infected children. J Clin Invest 95:2054-60

Showing the most recent 10 out of 16 publications